Bobby Gaspar

Bobby is a world-renowned scientist and physician and accomplished strategic and organizational leader with more than 25 years of experience in medicine and biotechnology. He is co-founder and chief executive officer of Orchard Therapeutics, a global gene therapy leader recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe. Bobby has been a pioneer in gene therapy and the evolution of hematopoietic stem cell (HSC) gene therapy —including some of the first studies in patients with severe primary immune deficiencies — bringing it from bench side research into late-stage clinical trials and demonstrating that gene therapy can potentially cure severe genetic diseases. He has led Orchard through the approval of Lib/Lenmeldy in the EU and USA for the treatment of metachromatic leukodystrophy (MLD). His unparalleled expertise and deep relationships with key physicians and treatment centers around the world are integral t